Care 4 more
ActiveCare 4 more has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €137k and a net result of €116k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 49% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
93
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency91▼-9
Growth32▼-46
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity ample (current ratio 2.9 against 10.61 in 2023; short-term debt: 33.2% and cash: 67.9% of total assets), and 33.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-07-2025, 2 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
2 d early
2023
13 d early
2022
3 d late
2021
2 d early
2020
5 d early
2019
40 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€137k▼ 45.0%
2023 · €249k
2019: €169k
2020: €307k
2021: €434k
2022: €461k
2023: €249k
2019 → 2024
Total assets
€207k▼ 24.7%
2023 · €275k
2019: €260k
2020: €380k
2021: €525k
2022: €514k
2023: €275k
2019 → 2024
Net result
€116k▼ 37.9%
2023 · €187k
2019: €151k
2020: €137k
2021: €127k
2022: €176k
2023: €187k
2019 → 2024
Working capital
€130k▼ 45.4%
2023 · €238k
2019: €156k
2020: €297k
2021: €425k
2022: €451k
2023: €238k
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€307k-€434k▲ 41.6%€461k▲ 6.3%€249k▼ 46.1%€137k▼ 45.0%
Operating result€178k-€166k▼ 6.7%€231k▲ 39.5%€246k▲ 6.4%€143k▼ 41.8%
Net result€137k-€127k▼ 7.2%€176k▲ 38.1%€187k▲ 6.3%€116k▼ 37.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 42% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €207k
Fixed assets
€8k▼ 29.3%
Current assets
€199k▼ 24.5%
Equity and liabilities €207k
Equity
€137k▼ 45.0%
Debt
€70k▲ 170%
The debt ratio rises from 9.4% to 33.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€146k▼
2023 · €249k
Cash flow
€120k▼
2023 · €191k
Solvency
66.2%▼
2023 · 90.6%
Current ratio
2.90▼
2023 · 10.61
Quick ratio
2.90▼
2023 · 10.61
Debt / equity
0.51▲
2023 · 0.10
ROE
84.9%▲
2023 · 75.3%
ROA
56.2%▼
2023 · 68.2%
Interest coverage
251.13▼
2023 · 417.99
Debt
€70k▲
2023 · €26k
Debt ≤ 1 year
€69k▲
2023 · €25k
Income taxes
€28k▼
2023 · €60k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€275k€207k▼
Formation expenses20€0€0=
Fixed assets21/28€11k€8k▼
Tangible fixed assets22/27€11k€8k▼
Land and buildings22€6k€4k▼
Furniture and vehicles24€5k€4k▼
Current assets29/58€263k€199k▼
Amounts receivable within one year40/41€6k€33k▲
Trade receivables40-€500
Other amounts receivable41€6k€32k▲
Current investments50/53€8k€20k▲
Cash at bank and in hand54/58€147k€140k▼
Deferred charges and accrued income490/1€103k€6k▼
Equity and liabilities
Total equity and liabilities10/49€275k€207k▼
Equity10/15€249k€137k▼
Contributions10/11€19k€19k=
Reserves13€230k€118k▼
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€228k€116k▼
Amounts payable17/49€26k€70k▲
Amounts payable after more than one year17€1k-
Financial debts170/4€1k-
Amounts payable within one year42/48€25k€69k▲
Current portion of amounts payable after more than one year42€3k€1k▼
Trade debts44€3k€5k▲
Suppliers440/4€3k€5k▲
Taxes, remuneration and social security45€19k€19k▲
Taxes450/3€19k€19k=
Remuneration and social security454/9-€35
Other amounts payable47/48-€43k
Accrued charges and deferred income492/3-€1k
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€3k=
Other operating charges640/8€2k€5k▲
Gross operating margin9900€251k€151k▼
Operating profit (loss)9901€246k€143k▼
Financial income75/76B€2k€2k▲
Recurring financial income75€2k€2k▲
Financial charges65/66B€596€583▼
Recurring financial charges65€596€583▼
Profit (loss) for the period before taxes9903€247k€144k▼
Income taxes67/77€60k€28k▼
Profit (loss) for the period9904€187k€116k▼
Profit (loss) for the period to be appropriated9905€187k€116k▼
Appropriation of the result
Profit (loss) to be appropriated9906€187k€116k▼
Transfer from equity791/2€400k€228k▼
Transfer to equity691/2€187k€116k▼
To other reserves6921€187k€116k▼
Profit to be distributed694/7€400k€228k▼
Return on contributions (dividend)694€400k€228k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €116k ▼37.9%
Net result drops to €116k, the lowest in the series.
18-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2019net €187k ▲6.3%
Operating result €246k, net result €187k, both a record.
03-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 3 days late
2022
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
26-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Equity above €200kEq €307k ▲81.2%
2 profitable years in a row build equity to €307k.
09-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 40 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kontich · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Duffelsesteenweg 1042550 KontichGround area
294 m²
Building footprint
122 m²
Parcel 11602E0033/00M002, Flanders. Linked by address, not a title deed.
1 establishment unit
Dr. C. Mallegho, urgentiegeneeskunde
since 20192.289.966.397
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11602E0033/00M002 | Flanders | 294 m² | 1 · 122 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GREY AND WHITE MATTER
BE 1000.398.117
Soignies · Eq €137k
SCornet
BE 1015.113.314
Dalhem · Eq €137k
MEDICM
BE 0728.957.077
Wellin · Eq €137k
Dr. Eline Borowski
BE 0792.533.253
Meerhout · Eq €137k
DR. KAREN DAM
BE 0755.624.060
Schilde · Eq €137k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,664 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-05-2019
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:christinemallegho@hotmail.com
E-mail:Christchristinemallegho@hotmail.com